@prefix dc: .
@prefix orcid: .
@prefix this: .
@prefix rdfs: .
@prefix xsd: .
@prefix sio: .
@prefix ncit: .
@prefix lld: .
@prefix miriam-gene: .
@prefix miriam-pubmed: .
@prefix eco: .
@prefix wi: .
@prefix prov: .
@prefix pav: .
@prefix prv: .
@prefix np: .
@prefix dgn-np: .
@prefix dgn-gda: .
@prefix dgn-void: .
dgn-np:NP808842.RAN2NTH8TTu379x5TE602EovTPOQCprwNYy1GzmnsRsoo130_head {
this: np:hasAssertion dgn-np:NP808842.RAN2NTH8TTu379x5TE602EovTPOQCprwNYy1GzmnsRsoo130_assertion;
np:hasProvenance dgn-np:NP808842.RAN2NTH8TTu379x5TE602EovTPOQCprwNYy1GzmnsRsoo130_provenance;
np:hasPublicationInfo dgn-np:NP808842.RAN2NTH8TTu379x5TE602EovTPOQCprwNYy1GzmnsRsoo130_publicationInfo;
a np:Nanopublication .
dgn-np:NP808842.RAN2NTH8TTu379x5TE602EovTPOQCprwNYy1GzmnsRsoo130_assertion a np:Assertion .
dgn-np:NP808842.RAN2NTH8TTu379x5TE602EovTPOQCprwNYy1GzmnsRsoo130_provenance a np:Provenance .
dgn-np:NP808842.RAN2NTH8TTu379x5TE602EovTPOQCprwNYy1GzmnsRsoo130_publicationInfo a
np:PublicationInfo .
}
dgn-np:NP808842.RAN2NTH8TTu379x5TE602EovTPOQCprwNYy1GzmnsRsoo130_assertion {
miriam-gene:5604 a ncit:C16612 .
lld:C0017638 a ncit:C7057 .
dgn-gda:DGNdb9fbaef09b939fcb9f26ba4ff0827db sio:SIO_000628 miriam-gene:5604, lld:C0017638;
a sio:SIO_001121 .
}
dgn-np:NP808842.RAN2NTH8TTu379x5TE602EovTPOQCprwNYy1GzmnsRsoo130_provenance {
dgn-np:NP808842.RAN2NTH8TTu379x5TE602EovTPOQCprwNYy1GzmnsRsoo130_assertion dc:description
"[We report here that: (a) in gliomas, [3H]TdR incorporation was enhanced by anti-Fas IgM monoclonal antibody CH-11 and conversely inhibited by anti-FasL monoclonal antibody NOK-2; (b) cross-linking of Fas with CH-11 drove both cell cycle progression and apoptosis as demonstrated by the induction of the S-G2 phase of DNA and RNA and fragmented nuclei; (c) phosphorylation of extracellular signal-regulated kinase (ERK), but not of c-Jun NH2-terminal kinase or p38, was induced by cross-linking of Fas; (d) a mitogen-activated protein kinase/ERK kinase 1 (MEK1) inhibitor PD98059 completely blocked CH-11-induced ERK phosphorylation as well as cell cycle progression without affecting induction of apoptosis; and (e) a broad-spectrum caspase inhibitor Z-Asp-CH2-DCB inhibited CH-11-induced ERK phosphorylation, cell cycle progression, and apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en;
wi:evidence dgn-void:source_evidence_literature;
sio:SIO_000772 miriam-pubmed:10749152;
prov:wasDerivedFrom dgn-void:befree-20140225;
prov:wasGeneratedBy eco:ECO_0000203 .
dgn-void:befree-20140225 pav:importedOn "2014-02-25"^^xsd:date .
dgn-void:source_evidence_literature a eco:ECO_0000212;
rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en;
rdfs:label "DisGeNET evidence - LITERATURE"@en .
}
dgn-np:NP808842.RAN2NTH8TTu379x5TE602EovTPOQCprwNYy1GzmnsRsoo130_publicationInfo {
this: dc:created "2014-10-02T12:40:16+02:00"^^xsd:dateTime;
dc:rights ;
dc:rightsHolder dgn-void:IBIGroup;
dc:subject sio:SIO_000983;
prv:usedData dgn-void:disgenetrdf;
pav:authoredBy orcid:0000-0001-5999-6269, orcid:0000-0002-7534-7661, orcid:0000-0002-9383-528X,
orcid:0000-0003-0169-8159, orcid:0000-0003-1244-7654;
pav:createdBy orcid:0000-0003-0169-8159;
pav:version "v2.1.0.0" .
dgn-void:disgenetrdf pav:version "v2.1.0" .
}